Human-induced pluripotent stem cells: potential for neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Human Molecular Genetics

• Publication date

  2014-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddu204PMID 24824217PMCID PMC4170718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death

  2014cited by this paper
• Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.

  2014cited by this paper
• LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction.

  2014cited by this paper
• Parkinson's disease in a dish - Using stem cells as a molecular tool.

  2014cited by this paper
• Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)

  2014cited by this paper
• C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease

  2014cited by this paper
• Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.

  2014cited by this paper
• Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors

  2014cited by this paper
• Huntington disease: natural history, biomarkers and prospects for therapeutics

  2014cited by this paper
• Stemming the Hype: What Can We Learn from iPSC Models of Parkinson's Disease and How Can We Learn It?

  2014cited by this paper
• The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.

  2014cited by this paper
• Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development

  2014cited by this paper
• Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

  2014cited by this paper
• Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia

  2014cited by this paper
• A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.

  2014cited by this paper
• High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

  2013cited by this paper
• Induced neural stem cells (iNSCs) in neurodegenerative diseases

  2013cited by this paper
• Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model

  2013cited by this paper
• EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs.

  2013cited by this paper
• Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy

  2013cited by this paper
• Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

  2013cited by this paper
• Deterministic direct reprogramming of somatic cells to pluripotency

  2013cited by this paper
• Modeling Huntington's disease with induced pluripotent stem cells.

  2013cited by this paper
• Neural stem cell‐based treatment for neurodegenerative diseases

  2013cited by this paper
• Neuronal Differentiation and Extensive Migration of Human Neural Precursor Cells following Co-Culture with Rat Auditory Brainstem Slices

  2013cited by this paper
• A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.

  2013cited by this paper
• Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations

  2013influential reference
• Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.

  2013cited by this paper
• RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

  2013cited by this paper
• Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

  2013cited by this paper
• Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.

  2013cited by this paper
• Pathways to decoding the clinical potential of stress response FOXO-interaction networks for Huntington's disease: of gene prioritization and context dependence

  2013cited by this paper
• Human iPSC-based modeling of late-onset disease via progerin-induced aging.

  2013cited by this paper
• Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• Back to the future: how human induced pluripotent stem cells will transform regenerative medicine

  2013cited by this paper
• Neural stem cells: generating and regenerating the brain.

  2013cited by this paper
• Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons

  2013cited by this paper
• Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.

  2013cited by this paper
• The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells.

  2013cited by this paper
• Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production

  2013cited by this paper
• Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis

  2013cited by this paper
• Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

  2013cited by this paper
• Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy*

  2013cited by this paper
• Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

  2013cited by this paper
• Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

  2013cited by this paper
• Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.

  2013cited by this paper
• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes

  2013influential reference
• Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

  2013cited by this paper
• Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

  2013cited by this paper
• Identification and Rescue of a-Synuclein Toxicity in Parkinson PatientDerived Neurons

  2013cited by this paper
• Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

  2012cited by this paper
• Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells

  2012cited by this paper
• Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.

  2012cited by this paper
• Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells

  2012cited by this paper
• Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient‐Derived Induced Pluripotent Stem Cells

  2012cited by this paper
• Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

  2012influential reference
• Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 In vitro

  2012cited by this paper
• Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

  2012cited by this paper
• Alzheimer's disease in a dish: promises and challenges of human stem cell models.

  2012cited by this paper
• Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.

  2012cited by this paper
• The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.

  2012cited by this paper
• Generation of induced pluripotent stem cells from skin fibroblasts of a patient with olivopontocerebellar atrophy.

  2012cited by this paper
• Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

  2012cited by this paper
• Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

  2012cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability

  2012influential reference
• Adapting human pluripotent stem cells to high-throughput and high-content screening

  2012cited by this paper
• Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research

  2012cited by this paper
• Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene

  2012cited by this paper
• Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

  2012cited by this paper
• Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells

  2012influential reference
• Altered Oxygen Metabolism Associated to Neurogenesis of Induced Pluripotent Stem Cells Derived from a Schizophrenic Patient

  2012cited by this paper
• LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

  2011cited by this paper
• Modelling schizophrenia using human induced pluripotent stem cells

  2011cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• In brief

  2011cited by this paper
• Specification of neuronal and glial subtypes from human pluripotent stem cells

  2011cited by this paper
• Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease

  2011cited by this paper
• Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD

  2011cited by this paper
• SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress

  2011cited by this paper
• Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients

  2011cited by this paper
• Huntington's disease: from molecular pathogenesis to clinical treatment

  2011cited by this paper
• EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Brief Report : Phenotypic Rescue of Induced Pluripotent Stem Cell-Derived Motoneurons of a Spinal Muscular Atrophy Patient

  2011cited by this paper
• Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.

  2011cited by this paper
• Specification of transplantable astroglial subtypes from human pluripotent stem cells

  2011cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Specification of Region-Specific Neurons Including Forebrain Glutamatergic Neurons from Human Induced Pluripotent Stem Cells

  2010cited by this paper
• Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

  2010cited by this paper
• Induced pluripotent stem cells from a spinal muscular atrophy patient

  2009influential reference
• Differentiation of human oligodendrocytes from pluripotent stem cells

  2009cited by this paper
• iPS cells produce viable mice through tetraploid complementation

  2009cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

  2009cited by this paper
• Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

  2009cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.

  2009cited by this paper
• Adult mice generated from induced pluripotent stem cells

  2009cited by this paper

• Stem Cell Therapies for Neurodegenerative Diseases: Emerging Frontiers in Regenerative Medicine

  2025cites this paper
• Roots of Progress: Uncovering Cerebellar Ataxias Using iPSC Models

  2025cites this paper
• Transplantation of human dental pulp stem cells promotes peripheral nerve regeneration after sciatic nerve injury in rats

  2024cites this paper
• Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration.

  2024cites this paper
• A comprehensive review of iPS cell line-based disease modelling of the polyglutamine spinocerebellar ataxias 2 and 3: a focus on the research outcomes

  2024cites this paper
• Stepwise dual-release microparticles of BMP-4 and SCF in induced pluripotent stem cell spheroids enhance differentiation into hematopoietic stem cells.

  2024cites this paper
• Advances of induced pluripotent stem cells in Alzheimer’s disease: A bibliometric analysis

  2024cites this paper
• miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease

  2023cites this paper
• Microarray analysis of lncRNAs and mRNAs in spinal cord contusion rats with iPSC-derived A2B5+ oligodendrocyte precursor cells transplantation

  2023cites this paper
• Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review

  2023cites this paper
• Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases

  2023cites this paper
• Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application

  2023cites this paper
• N-Acetylglucosamine Kinase–Small Nuclear Ribonucleoprotein Polypeptide N Interaction Promotes Axodendritic Branching in Neurons via Dynein-Mediated Microtubule Transport

  2023cites this paper
• Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases.

  2023cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• New Prospects for Stem Cell Therapy in Alzheimer’s Disease

  2021cites this paper
• Enhanced integrin affinity and neural differentiation of induced pluripotent stem cells using Ln5-P4-grafted amphiphilic solid lipid nanoparticles.

  2021cites this paper
• Stem cell in neurodegenerative disorders; an emerging strategy

  2021cites this paper
• Brain-derived neurotrophic factor increases cell number of neural progenitor cells derived from human induced pluripotent stem cells

  2021cites this paper
• Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.

  2021cites this paper
• Recent Advances in Stem Cell Therapy for Parkinson’s Disease

  2020cites this paper
• Longitudinal Characterization of Transcriptomic, Functional, and Morphological Features in Human iPSC-Derived Neurons and Their Application to Investigate Translational Progranulin Disease Biology

  2020cites this paper
• The stress–Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches

  2020cites this paper
• Transcriptome Analysis as a Tool for Investigation of Pathogenesis of Chromosomal Diseases

  2020cites this paper
• Induced pluripotent stem cells (iPSCs) as game‐changing tools in the treatment of neurodegenerative disease: Mirage or reality?

  2020cites this paper
• Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms.

  2020cites this paper
• Neuroregeneration: Regulation in Neurodegenerative Diseases and Aging

  2020cites this paper
• Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseases

  2019cites this paper
• New treatment modalities in Alzheimer's disease

  2019cites this paper
• Application of Urine-Derived Stem Cells to Cellular Modeling in Neuromuscular and Neurodegenerative Diseases

  2019cites this paper
• Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias

  2019cites this paper
• Modeling Brain Disorders Using Induced Pluripotent Stem Cells.

  2019cites this paper
• Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer’s Disease

  2019cites this paper
• Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy

  2019cites this paper
• Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides

  2019influential citation
• The Role of PI3K/Akt and ERK in Neurodegenerative Disorders

  2019cites this paper
• Genetic reprogramming of somatic cells into neuroblasts through a co-induction of the doublecortin gene along the Yamanaka factors: A promising approach to model neuroregenerative disorders.

  2019cites this paper
• Past, Present, and Future of Neuronal Models In Vitro.

  2019cites this paper
• Modeling Inflammation in Autism Spectrum Disorders Using Stem Cells

  2018cites this paper
• Pluripotent Stem Cells for Uncovering the Role of Mitochondria in Human Brain Function and Dysfunction.

  2018cites this paper
• Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech

  2018cites this paper
• Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy

  2018cites this paper
• Materials for Neural Differentiation, Trans‐Differentiation, and Modeling of Neurological Disease

  2018cites this paper
• CRISPR/Cas9: a Revolution towards Treatment for Neurodegenerative Disorders

  2018cites this paper
• Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease

  2018cites this paper
• Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

  2018cites this paper
• Efficient production of erythroid, megakaryoid and myeloid cells, using single cell-derived iPSC colony differentiation

  2018cites this paper
• Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks

  2018cites this paper
• Integrating Omics data : a new software tool and its use in implicating therapeutic targets in Huntington's disease

  2018cites this paper
• Hype and Hopes of Stem Cell Research in Neurodegenerative Diseases

  2017cites this paper
• Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling.

  2017cites this paper
• Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?

  2017cites this paper
• Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation

  2017cites this paper
• Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls

  2017cites this paper
• Human induced pluripotent stem cells as a research tool in Alzheimer's disease

  2017cites this paper
• Stem Cell Technology for (Epi)genetic Brain Disorders.

  2017cites this paper
• Modulation of human mesenchymal and pluripotent stem cell behavior using biophysical and biochemical cues: A review

  2017cites this paper
• Regenerative Medicine: Laboratory to Clinic

  2017influential citation
• Soluble expression of recomb inant cMyc, Klf4, Oct4, and Sox2 proteins in bacteria and transduction into living cells.

  2017cites this paper
• The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.

  2017cites this paper
• Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries

  2017cites this paper
• Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish

  2017cites this paper
• Three-Dimensional Hyaluronic Acid Hydrogel-Based Models for In Vitro Human iPSC-Derived NPC Culture and Differentiation.

  2017cites this paper
• Human induced pluripotent stem cells as a research tool in

  2017cites this paper
• Title Phosphorylation of huntingtin at residue T 3 is decreased in Huntington ' s disease and modulates mutant huntingtin protein conformation Permalink

  2017cites this paper
• Pluripotent Stem Cells to Model and Treat Huntington’s Disease

  2017cites this paper
• Transcriptional response of Hoxb genes to retinoid signalling is regionally restricted along the neural tube rostrocaudal axis

  2017cites this paper
• Post transcriptional regulation of microRNAs in embryonic stem cells

  2017cites this paper
• Genetics of neurodegenerative diseases: an overview.

  2017cites this paper
• Current Topics in Deep Brain Stimulation for Parkinson Disease

  2016cites this paper
• Investigation of the cell- and non-cell autonomous impact of the C9orf72 mutation on human induced pluripotent stem cell-derived astrocytes

  2016cites this paper
• HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases

  2016cites this paper
• Matériaux et procédés de traitement de la sclérose latérale amyotrophique et/ou de la dégénérescence lobaire frontotemporale

  2016cites this paper
• Therapeutic advances in Huntington’s disease

  2016cites this paper
• Pluripotent stem cells and their use in hearing loss

  2016influential citation
• Personalized Medicine Approaches in Parkinson’s Disease: The Genetic Perspective

  2016cites this paper
• Comparative transcriptome analysis in induced neural stem cells reveals defined neural cell identities in vitro and after transplantation into the adult rodent brain.

  2016cites this paper
• Current status of stem cell therapy: opportunities and limitations

  2016cites this paper
• Développement et validation d'outils pour l'analyse morphologique du cerveau de Macaque. (Morphometry Analysis Tools for the Macaque Brain : Development and Validation)

  2016cites this paper
• Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies

  2016cites this paper
• Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.

  2016cites this paper
• Development of stem cell-based therapies for Parkinson's disease

  2016cites this paper
• Anti‐diabetic and neuroprotective effects of pancreatic islet transplantation into the central nervous system

  2016cites this paper
• Induced pluripotent stem cells and Parkinson's disease: modelling and treatment

  2016cites this paper
• Generation of Cholinergic and Dopaminergic Interneurons from Human Pluripotent Stem Cells as a Relevant Tool for In Vitro Modeling of Neurological Disorders Pathology and Therapy

  2016cites this paper
• Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming

  2016cites this paper
• Erratum

  2016cites this paper
• Repair of cartilage defects in osteoarthritis rats with induced pluripotent stem cell derived chondrocytes

  2016cites this paper
• Use of human stem cells in Huntington disease modeling and translational research.

  2016cites this paper
• Clinicogenetic and functional studies in rare hereditary neurodegenerative movement disorders

  2016cites this paper
• Substrates and Surfaces for Control of Pluripotent Stem Cell Fate and Function

  2016cites this paper
• In vitro models for neurotoxicology research

  2015cites this paper
• Optimizing Differentiation Protocols for Producing Dopaminergic Neurons from Human Induced Pluripotent Stem Cells for Tissue Engineering Applications

  2015cites this paper
• Methods of induced pluripotent stem cells for clinical application.

  2015cites this paper
• Significance of Mechanism-Oriented Research Toward Neuronal Protection Therapy Against Neurodegenerative Disorders ~ ZNRF1 E3 Ubiquitin Ligase as a Critical Mediator for Wallerian Degeneration and Neuronal Apoptosis

  2015cites this paper
• Development of stem cell-based therapy for Parkinson’s disease

  2015cites this paper
• A Quantitative Approach to Characterize MR Contrasts with Histology

  2015cites this paper
• Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.

  2015cites this paper
• Stem cells - biological update and cell therapy progress

  2015cites this paper
• Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models

  2015cites this paper